Phio Pharmaceuticals Corp. (NASDAQ: PHIO) reported Q2 EPS of ($0.36), $0.06 worse than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Phio Pharmaceuticals Corp. (PHIO) click here.